QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
For
the quarterly period ended June
30, 2007
|
Delaware
|
22-2786081
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
Identification
No.)
|
|
200
Route 17, Mahwah, New Jersey
|
07430
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Class
|
Outstanding
at August 14, 2007
|
|
Common
Stock, $0.01 par value per share
|
10,117,943
shares
|
PART
I. Financial
Information
|
||
Financial
Statements
|
||
|
||
Unaudited
Consolidated Financial Statements:
|
||
|
||
Consolidated
Balance Sheets as of December 31, 2006 and June 30, 2007
|
1
|
|
|
||
Consolidated
Statements of Operations for the three and six month periods ended
June
30, 2006 and 2007
|
2
|
|
|
||
Consolidated
Statement of Changes in Shareholders’ Equity for the six month period
ended June 30, 2007
|
3
|
|
|
||
Consolidated
Statements of Cash Flows for the three and six month periods ended
June
30, 2006 and 2007
|
4
|
|
|
||
Notes
to Consolidated Financial Statements
|
6
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
15
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
23
|
Item
4T.
|
Controls
and Procedures
|
23
|
PART
II. Other
Information
|
||
Item
1.
|
Legal
Proceedings
|
25
|
Item
1A.
|
Risk
Factors
|
25
|
Exhibits
|
26
|
|
Signatures
|
27
|
|
As
of
December
31,
2006
|
As
of
June
30,
2007
|
|||||
(unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
1,521
|
$
|
5,127
|
|||
Accounts
receivable, net
|
1,373
|
830
|
|||||
Unbilled
work-in-process
|
393
|
494
|
|||||
Other
current assets
|
316
|
1,686
|
|||||
Total
current assets
|
3,603
|
8,137
|
|||||
Property
and equipment, net
|
445
|
551
|
|||||
Investment
in Comverge
|
—
|
28,387
|
|||||
Investment
in Paketeria
|
1,212
|
875
|
|||||
Funds
in respect of employee termination benefits
|
1,568
|
1,360
|
|||||
Goodwill
|
97
|
95
|
|||||
Other
intangible assets, net
|
48
|
9
|
|||||
Other
assets
|
285
|
170
|
|||||
Total
assets
|
$
|
7,258
|
$
|
39,584
|
|||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Short-term
bank credit
|
$
|
462
|
$
|
166
|
|||
Current
maturities of long-term debt
|
26
|
71
|
|||||
Note
payable - related party
|
300
|
—
|
|||||
Trade
accounts payable
|
378
|
430
|
|||||
Accrued
payroll, payroll taxes and social benefits
|
478
|
863
|
|||||
Other
current liabilities
|
1,700
|
2,125
|
|||||
Total
current liabilities
|
3,344
|
3,655
|
|||||
Long-term
liabilities:
|
|||||||
Investment
in Comverge, net
|
1,824
|
—
|
|||||
Convertible
debt, net of discounts
|
—
|
4,470
|
|||||
Liability
for employee termination benefits
|
2,545
|
1,968
|
|||||
Other
liabilities
|
6
|
3
|
|||||
Total
long-term liabilities
|
4,375
|
6,441
|
|||||
Shareholders’
equity:
|
|||||||
Common
stock - $0.01 par value per share:
|
|||||||
Authorized
- 20,000,000 shares; Issued -10,276,030 shares and 10,451,905
at
December 31, 2006 and June 30, 2007
|
102
|
104
|
|||||
Additional
paid-in capital
|
43,987
|
47,535
|
|||||
Warrants
|
888
|
1,629
|
|||||
Accumulated
deficit
|
(41,904
|
)
|
(30,295
|
)
|
|||
Treasury
stock, at cost - 777,371 shares for December 31, 2006 and
June
30, 2007, respectively
|
(3,592
|
)
|
(3,592
|
)
|
|||
Accumulated
other comprehensive income
|
58
|
14,107
|
|||||
Total
shareholders’ equity (deficit)
|
(461
|
)
|
29,488
|
||||
Total
liabilities and shareholders’ equity
|
$
|
7,258
|
$
|
39,584
|
Six
months ended
June
30,
|
Three
months ended
June
30,
|
||||||||||||
2006
|
2007
|
2006
|
2007
|
||||||||||
Sales:
|
|||||||||||||
Projects
|
$
|
1,521
|
1,287
|
$
|
791
|
$
|
475
|
||||||
Services
|
434
|
403
|
197
|
197
|
|||||||||
Other
|
8
|
30
|
2
|
9
|
|||||||||
Total
sales
|
1,963
|
1,720
|
990
|
681
|
|||||||||
Cost
of sales:
|
|||||||||||||
Projects
|
1,021
|
1,042
|
482
|
461
|
|||||||||
Services
|
369
|
337
|
163
|
164
|
|||||||||
Other
|
—
|
—
|
—
|
—
|
|||||||||
Total
cost of sales
|
1,390
|
1,379
|
645
|
625
|
|||||||||
Gross
profit
|
573
|
341
|
345
|
56
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development expenses
|
97
|
233
|
71
|
103
|
|||||||||
Selling,
marketing, general and administrative expenses
|
1,966
|
1,859
|
1,044
|
1,049
|
|||||||||
Total
operating expenses
|
2,063
|
2,092
|
1,115
|
1,152
|
|||||||||
Operating
loss
|
(1,490
|
)
|
(1,751
|
)
|
(770
|
)
|
(1,096
|
)
|
|||||
Finance
expense, net
|
(6
|
)
|
(2,111
|
)
|
(20
|
)
|
(1,258
|
)
|
|||||
Gain
on public offering of Comverge
|
—
|
16,169
|
—
|
16,169
|
|||||||||
Other
income, net
|
330
|
—
|
—
|
—
|
|||||||||
Income
(loss) before taxes on income
|
(1,166
|
)
|
12,307
|
(790
|
)
|
13,815
|
|||||||
Taxes
on income
|
(6
|
)
|
(5
|
)
|
(4
|
)
|
(3
|
)
|
|||||
Income
(loss) from operations of the Company and its consolidated
subsidiaries
|
(1,172
|
)
|
12,302
|
(794
|
)
|
13,812
|
|||||||
Share
of losses in Comverge
|
(210
|
)
|
—
|
—
|
—
|
||||||||
Share
of losses in Paketeria
|
—
|
(388
|
)
|
—
|
(201
|
)
|
|||||||
Net
income (loss) from continuing operations
|
(1,382
|
)
|
11,914
|
(794
|
)
|
13,611
|
|||||||
Net
income from discontinued operations, net of tax
|
78
|
—
|
—
|
—
|
|||||||||
Loss
on sale of discontinued operations and contract settlement, net of
tax
|
(2,298
|
)
|
—
|
—
|
—
|
||||||||
Net
income (loss)
|
$
|
(3,602
|
)
|
$
|
11,914
|
$
|
(794
|
)
|
$
|
13,611
|
|||
Basic
net income (loss) per share:
|
|||||||||||||
Income
(loss) per share from continuing operations
|
$
|
(0.17
|
)
|
$
|
1.25
|
$
|
(0.10
|
)
|
$
|
1.42
|
|||
Discontinued
operations
|
(0.27
|
)
|
—
|
—
|
—
|
||||||||
Net
income (loss) per share - basic
|
$
|
(0.44
|
)
|
$
|
1.25
|
$
|
(0.10
|
)
|
$
|
1.42
|
|||
Diluted
net income (loss) per share:
|
|||||||||||||
Income
(loss) per share from continuing operations
|
$
|
(0.17
|
)
|
$
|
1.05
|
$
|
(0.10
|
)
|
$
|
1.11
|
|||
Discontinued
operations
|
(0.27
|
)
|
—
|
—
|
—
|
||||||||
Net
income (loss) per share -diluted
|
$
|
(0.44
|
)
|
$
|
1.05
|
$
|
(0.10
|
)
|
$
|
1.11
|
|||
Weighted
average number of shares outstanding -
|
|||||||||||||
Basic
|
8,152
|
9,549
|
8,161
|
9,583
|
|||||||||
Diluted
|
8,152
|
11,560
|
8,161
|
12,463
|
Number
of Shares
|
Common
Stock
|
Additional
Paid-In
Capital
|
Warrants
|
Accumulated
Deficit
|
Treasury
Stock
|
Accumulated
Other Comprehensive Income
|
Total
|
||||||||||||||||||
Balances
as of December
31, 2006
|
10,276
|
$
|
102
|
$
|
43,987
|
$
|
888
|
$
|
(41,904
|
)
|
$
|
(3,592
|
)
|
$
|
58
|
$
|
(461
|
)
|
|||||||
Net
income
|
—
|
—
|
—
|
—
|
11,914
|
—
|
—
|
11,914
|
|||||||||||||||||
FAS
115 adjustment on Comverge shares, net of deferred taxes
|
—
|
—
|
—
|
—
|
—
|
—
|
14,043
|
14,043
|
|||||||||||||||||
Differences
from translation of financial statements of subsidiaries
|
—
|
—
|
—
|
—
|
—
|
—
|
6
|
6
|
|||||||||||||||||
Comprehensive
income
|
25,963
|
||||||||||||||||||||||||
FIN
48 adjustment
|
—
|
—
|
—
|
—
|
(305
|
)
|
—
|
—
|
(305
|
)
|
|||||||||||||||
Exercise
of options and warrants
|
176
|
2
|
504
|
(3
|
)
|
—
|
—
|
—
|
503
|
||||||||||||||||
Adjustment
of transaction costs of prior year private placement
|
—
|
—
|
68
|
—
|
—
|
—
|
—
|
68
|
|||||||||||||||||
Warrants
issued to placement agent with respect to private placement of
Debentures
|
—
|
—
|
—
|
213
|
—
|
—
|
—
|
213
|
|||||||||||||||||
Warrants
issued with respect to private placement of Debentures
|
—
|
—
|
—
|
531
|
—
|
—
|
—
|
531
|
|||||||||||||||||
Beneficial
conversion feature with respect to private placement of
Debentures
|
—
|
—
|
2,570
|
—
|
—
|
—
|
—
|
2,570
|
|||||||||||||||||
Stock
option compensation
|
—
|
—
|
406
|
—
|
—
|
—
|
—
|
406
|
|||||||||||||||||
Balances
as of June
30, 2007
|
10,452
|
$
|
104
|
$
|
47,535
|
$
|
1,629
|
$
|
(30,295
|
)
|
$
|
(3,592
|
)
|
$
|
14,107
|
$
|
29,488
|
Six
months ended
June
30,
|
|||||||
2006
|
2007
|
||||||
Cash
flows provided by (used in) operating activities:
|
|||||||
Net
income (loss)
|
$
|
(3,602
|
)
|
$
|
11,914
|
||
Adjustments
to reconcile net income (loss) to net cash
provided
by (used in) operating activities:
|
|||||||
Depreciation
and amortization
|
112
|
67
|
|||||
Impairment
of software license
|
—
|
23
|
|||||
Share
in losses of Comverge
|
210
|
—
|
|||||
Share
in losses of Paketeria
|
—
|
356
|
|||||
Decrease
in liability for employee termination benefits
|
(25
|
)
|
(250
|
)
|
|||
Amortization
of stock-based deferred compensation
|
462
|
406
|
|||||
Loss
on sale of Databit and contract settlement
|
2,298
|
—
|
|||||
Amortization
of beneficial conversion feature, debt origination costs and value
of
warrants in private placement of Debentures
|
—
|
1,945
|
|||||
Gain
on public offering of investment in Comverge
|
—
|
(16,169
|
)
|
||||
Other
|
3
|
(1
|
)
|
||||
Change
in operating assets and liabilities:
|
|||||||
Decrease
in accounts receivable, unbilled work-in process and other current
and
other assets
|
68
|
417
|
|||||
Increase
in inventory
|
(18
|
)
|
—
|
||||
Increase
(decrease) in accounts payable and other liabilities
|
(656
|
)
|
295
|
||||
Net
cash used in operating activities
|
(1,148
|
)
|
(997
|
)
|
|||
Cash
flows provided by (used in) investing activities:
|
|||||||
Release
of restricted cash
|
247
|
—
|
|||||
Release
of restricted cash (under agreement with a related party)
|
1,350
|
—
|
|||||
Investment
in Comverge
|
(210
|
)
|
—
|
||||
Short-term
loans provided to Paketeria
|
—
|
(733
|
)
|
||||
Amounts
funded for employee termination benefits
|
(82
|
)
|
(26
|
)
|
|||
Utilization
of employee termination benefits
|
97
|
62
|
|||||
Acquisitions
of property and equipment
|
(78
|
)
|
(167
|
)
|
|||
Sale
of Databit Inc. - Appendix A
|
(911
|
)
|
—
|
||||
Net
cash provided by (used in) investing activities
|
413
|
(864
|
)
|
||||
Cash
flows provided by (used in) financing activities:
|
|||||||
Short-term
debt repayments, net
|
22
|
(296
|
)
|
||||
Proceeds
from long-term debt
|
—
|
107
|
|||||
Proceeds
from convertible debentures with warrants net of transaction
costs
|
—
|
5,840
|
|||||
Repayments
of long-term debt
|
(74
|
)
|
(62
|
)
|
|||
Repayment
of related party note payable
|
—
|
(300
|
)
|
||||
Proceeds
from employee stock option and warrant exercises
|
44
|
178
|
|||||
Net
cash provided by (used in) financing activities
|
(8
|
)
|
5,467
|
||||
Net
increase (decrease) in cash and cash equivalents
|
(743
|
)
|
3,606
|
||||
Cash
and cash equivalents at beginning of period
|
913
|
1,521
|
|||||
Cash
and cash equivalents at end of period
|
$
|
170
|
$
|
5,127
|
Non-cash
financing and investing items
|
|||||||
Value
of beneficial conversion feature upon issuance of convertible
debentures
|
$
|
2,570
|
|||||
Unrealized
gain from Comverge shares
|
$
|
14,043
|
|||||
Amount
due from broker on account of options exercised
|
$
|
325
|
|||||
Adjustment
of retained earnings and other current liabilities with respect to
the
adoption of FIN 48
|
$
|
305
|
|||||
Appendix
A
|
|||||||
Assets/liabilities
disposed of in disposition of Databit Inc. and contract
settlement:
|
|||||||
Current
assets
|
$
|
2,815
|
|||||
Non-current
assets
|
40
|
||||||
Debt
|
(20
|
)
|
|||||
Current
liabilities
|
(1,816
|
)
|
|||||
Stock
compensation costs
|
315
|
||||||
Unpaid
transaction costs in disposition of Databit and contract
settlement
|
63
|
||||||
Other
|
(10
|
)
|
|||||
Loss
on the sale of Databit and contract settlement
|
$
|
(2,298
|
)
|
||||
Net
cash used in business disposition
|
$
|
(911
|
)
|
Six
months
ended
June 30, 2007
|
Three
months
ended
June 30, 2007
|
||||||
Sales
|
$
|
1,514
|
$
|
939
|
|||
Gross
loss
|
$
|
(190
|
)
|
$
|
(83
|
)
|
|
Net
loss
|
$
|
(895
|
)
|
$
|
(492
|
)
|
Six
months ended June 30, 2007
|
Three
months ended June 30, 2007
|
||||||
Equity
loss in Paketeria
|
$
|
(293
|
)
|
$
|
(161
|
)
|
|
Amortization
expense associated with acquired non-compete and franchise agreements
and
change in value of put option
|
(63
|
)
|
(27
|
)
|
|||
Stock
compensation expense
|
(32
|
)
|
(13
|
)
|
|||
Share
of losses in Paketeria
|
$
|
(388
|
)
|
$
|
(201
|
)
|
Investment
balance as of December 31, 2006
|
$
|
1,212
|
||
Amortization
of acquired non-compete and franchise agreements and change in value
of
put option
|
(63
|
)
|
||
Cumulative
translation adjustment
|
19
|
|||
Company’s
share of Paketeria losses - period from January 1, 2007 to June 30,
2007
|
(293
|
)
|
||
Investment
balance as of June 30, 2007
|
$
|
875
|
Number
of Options (in shares)
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Life
|
Aggregate
Intrinsic Value
|
||||||||||
Outstanding
at December 31, 2006
|
2,172,835
|
$
|
2.55
|
||||||||||
Granted
at market price
|
66,000
|
$
|
4.53
|
||||||||||
Granted
at discount to market price
|
79,000
|
$
|
3.50
|
||||||||||
Exercised
|
(173,500
|
)
|
$
|
2.86
|
$
|
270
|
|||||||
Forfeited
or expired
|
(92,667
|
)
|
$
|
3.64
|
|||||||||
Outstanding
at June 30, 2007
|
2,051,668
|
$
|
2.58
|
2.9
years
|
$
|
5,595
|
|||||||
Exercisable
at June 30, 2007
|
1,563,334
|
$
|
2.43
|
2.3
years
|
$
|
4,515
|
Volatility
|
50
|
%
|
||
Expected
term (years)
|
1.0
years
|
|||
Risk
free interest rate
|
5.0
|
%
|
||
Expected
dividend yield
|
0.0
|
%
|
Six
months ended June 30, 2006
|
Six
months ended June 30, 2007
|
Three
months ended June 30, 2006
|
Three
months ended June 30, 2007
|
||||||||||
Cost
of sales
|
$
|
21
|
$
|
22
|
$
|
2
|
$
|
1
|
|||||
Selling,
marketing, general and administrative expenses
|
441
|
352
|
325
|
103
|
|||||||||
Share
of losses in Paketeria
|
—
|
32
|
—
|
13
|
|||||||||
Loss
on sale of discontinued operations and contract settlement
|
315
|
—
|
—
|
—
|
|||||||||
Total
stock based compensation expense
|
$
|
777
|
$
|
406
|
$
|
327
|
$
|
117
|
Number
of Warrants (in shares)
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Life
|
||||||||
Outstanding
at December 31, 2006
|
614,039
|
$
|
2.79
|
3.2
years
|
||||||
Granted
|
746,916
|
$
|
4.50
|
4.8
years
|
||||||
Exercised
|
(2,375
|
)
|
$
|
2.78
|
||||||
Forfeited
or expired
|
—
|
—
|
||||||||
Outstanding
at June 30, 2007
|
1,358,580
|
$
|
3.73
|
3.9
years
|
||||||
Exercisable
at June 30, 2007
|
1,358,580
|
$
|
3.73
|
3.9
years
|
· |
RT
Solutions whose activities are focused on two areas - naval solutions
and
other real-time and embedded hardware & software
development.
|
· |
OncoPro™
whose activities are comprised of the Company’s OncoPro™ solution state of
the art chemotherapy package for oncology and hematology
departments.
|
RT
Solutions
|
OncoPro™
|
Other
(*)
|
Total
|
||||||||||
Six
months ended June 30, 2007:
|
|||||||||||||
Revenues
from external customers
|
$
|
1,103
|
$
|
269
|
$
|
348
|
$
|
1,720
|
|||||
Intersegment
revenues
|
—
|
—
|
—
|
—
|
|||||||||
Segment
gross profit (loss)
|
261
|
108
|
(28
|
)
|
341
|
||||||||
Segment
loss
|
(233
|
)
|
(219
|
)
|
(130
|
)
|
(582
|
)
|
|||||
Six
months ended June 30, 2006:
|
|||||||||||||
Revenues
from external customers
|
$
|
1,334
|
$
|
315
|
$
|
314
|
$
|
1,963
|
|||||
Intersegment
revenues
|
—
|
—
|
—
|
—
|
|||||||||
Segment
gross profit
|
487
|
55
|
31
|
573
|
|||||||||
Segment
income (loss)
|
(36
|
)
|
(114
|
)
|
(68
|
)
|
(218
|
)
|
|||||
Three
months ended June 30, 2007:
|
|||||||||||||
Revenues
from external customers
|
$
|
424
|
$
|
97
|
$
|
160
|
$
|
681
|
|||||
Intersegment
revenues
|
—
|
—
|
—
|
—
|
|||||||||
Segment
gross profit (loss)
|
86
|
12
|
(42
|
)
|
56
|
||||||||
Segment
income (loss)
|
(269
|
)
|
(157
|
)
|
(130
|
)
|
(556
|
)
|
|||||
Three
months ended June 30, 2006:
|
|||||||||||||
Revenues
from external customers
|
$
|
702
|
$
|
144
|
$
|
144
|
$
|
990
|
|||||
Intersegment
revenues
|
—
|
—
|
—
|
—
|
|||||||||
Segment
gross profit
|
327
|
13
|
5
|
345
|
|||||||||
Segment
income (loss)
|
13
|
(77
|
)
|
(37
|
)
|
(101
|
)
|
Six
months ended June 30,
|
Three
months ended June 30,
|
||||||||||||
2006
|
2007
|
2006
|
2007
|
||||||||||
Total
loss for reportable segments
|
$
|
(150
|
)
|
$
|
(452
|
)
|
$
|
(64
|
)
|
$
|
(426
|
)
|
|
Other
operational segment loss
|
(68
|
)
|
(130
|
)
|
(37
|
)
|
(130
|
)
|
|||||
Total
operating loss
|
(218
|
)
|
(582
|
)
|
(101
|
)
|
(556
|
)
|
|||||
Share
of losses in Paketeria
|
—
|
(388
|
)
|
—
|
(201
|
)
|
|||||||
Share
of losses in Comverge
|
(210
|
)
|
—
|
—
|
—
|
||||||||
Gain
recorded on Comverge public offering
|
—
|
16,169
|
—
|
16,169
|
|||||||||
Net
loss of corporate headquarters and other unallocated costs
|
(954
|
)
|
(3,285
|
)
|
(693
|
)
|
(1,801
|
)
|
|||||
Net
loss from continuing operations
|
(1,382
|
)
|
11,914
|
(794
|
)
|
13,611
|
|||||||
Discontinued
operations
|
78
|
—
|
—
|
—
|
|||||||||
Loss
on sale of discontinued operations and contract settlement
|
(2,298
|
)
|
—
|
—
|
—
|
||||||||
Total
consolidated net income (loss)
|
$
|
(3,602
|
)
|
$
|
11,914
|
$
|
(794
|
)
|
$
|
13,611
|
*
Includes $1,946 and $1,119 of during the six and three months ended
June
30, 2007, respectively, of interest expense with respect to the private
placement of Debentures (see Note
8).
|
Six
months ended June 30,
|
Three
months ended June 30,
|
||||||||||||||||||||||||||||||
2006
|
2007
|
Change
|
2006
|
2007
|
Change
|
||||||||||||||||||||||||||
($,000)
|
%
of sales
|
($,000)
|
%
of sales
|
%
of 2006
|
($,000)
|
%
of sales
|
($,000)
|
%
of sales
|
%
of 2006
|
||||||||||||||||||||||
Sales
|
$
|
1,963
|
100
|
%
|
$
|
1,720
|
100
|
%
|
(12
|
)
|
990
|
100
|
%
|
$
|
681
|
100
|
%
|
(31
|
)
|
||||||||||||
Cost
of sales
|
1,390
|
71
|
1,379
|
80
|
(1
|
)
|
645
|
65
|
625
|
92
|
(3
|
)
|
|||||||||||||||||||
Gross
profit
|
573
|
29
|
341
|
20
|
(40
|
)
|
345
|
35
|
56
|
8
|
(84
|
)
|
|||||||||||||||||||
R&D
expenses
|
97
|
5
|
233
|
14
|
140
|
71
|
7
|
103
|
15
|
45
|
|||||||||||||||||||||
SMG&A
expenses
|
1,966
|
100
|
1,859
|
108
|
(5
|
)
|
1,044
|
105
|
1,049
|
154
|
0
|
||||||||||||||||||||
Operating
loss
|
(1,490
|
)
|
(76
|
)
|
(1,751
|
)
|
(102
|
)
|
18
|
(770
|
)
|
(78
|
)
|
(1,096
|
)
|
(161
|
)
|
42
|
|||||||||||||
Finance
expense, net
|
(6
|
)
|
0
|
(2,111
|
)
|
(123
|
)
|
35,083
|
(20
|
)
|
(2
|
)
|
(1,258
|
)
|
(185
|
)
|
6,290
|
||||||||||||||
Gain
on public offering of Comverge
|
—
|
—
|
16,169
|
940
|
—
|
—
|
16,169
|
2,374
|
|||||||||||||||||||||||
Other
income, net
|
330
|
17
|
—
|
—
|
(100
|
)
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||
Income
(loss) before taxes on income
|
(1,166
|
)
|
(59
|
)
|
12,307
|
716
|
(1,155
|
)
|
(790
|
)
|
(80
|
)
|
13,815
|
2,029
|
(1,849
|
)
|
|||||||||||||||
Taxes
on income
|
(6
|
)
|
0
|
(5
|
)
|
0
|
(17
|
)
|
(4
|
)
|
0
|
(3
|
)
|
0
|
(25
|
)
|
|||||||||||||||
Income
(loss) from operations of the Company and its consolidated
subsidiaries
|
(1,172
|
)
|
(60
|
)
|
12,302
|
715
|
(1,150
|
)
|
(794
|
)
|
(80
|
)
|
13,812
|
2,028
|
(1,840
|
)
|
|||||||||||||||
Share
in losses in Paketeria
|
—
|
—
|
(388
|
)
|
(23
|
)
|
—
|
—
|
(201
|
)
|
(30
|
)
|
|||||||||||||||||||
Share
in losses in Comverge
|
(210
|
)
|
(11
|
)
|
—
|
(100
|
)
|
—
|
—
|
—
|
—
|
||||||||||||||||||||
Net
loss from continuing operations
|
(1,382
|
)
|
(70
|
)
|
11,914
|
693
|
(962
|
)
|
(794
|
)
|
(80
|
)
|
13,611
|
1,999
|
(1,814
|
)
|
|||||||||||||||
Net
income from discontinued operations, net of tax
|
78
|
4
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||||||
Loss
on sale of discontinued operations and contract settlement
|
(2,298
|
)
|
(117
|
)
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||||
Net
income (loss)
|
$
|
(3,602
|
)
|
(183
|
)
|
$
|
11,914
|
693
|
(431
|
)
|
$
|
(794
|
)
|
(80
|
)
|
$
|
13,611
|
1,999
|
(1,814
|
)
|
Cash
Payments Due During Year Ending June 30,
|
||||||||||||||||
Contractual
Obligations
|
Total
|
2008
|
2009-2010
|
2011-2012
|
2013
and thereafter
|
|||||||||||
(amounts
in thousands)
|
||||||||||||||||
Long-term
debt
|
$
|
6,886
|
$
|
—
|
$
|
—
|
$
|
6,886
|
$
|
—
|
||||||
Operating
leases (1)
|
874
|
487
|
387
|
—
|
—
|
|||||||||||
Potential
severance obligations to Israeli employees (2)
|
2,295
|
327
|
—
|
—
|
1,968
|
|||||||||||
Investor
relations
|
12
|
12
|
—
|
—
|
—
|
|||||||||||
Buy-out
of Paketeria loan (3)
|
94
|
94
|
—
|
—
|
—
|
|||||||||||
Total
contractual cash obligations
|
$
|
10,161
|
$
|
920
|
$
|
387
|
$
|
6,886
|
$
|
1,968
|
31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
31.2
|
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
32.1
|
Certification
of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
|
32.2
|
Certification
of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
ACORN FACTOR, INC. | ||
|
|
|
Dated: August 20, 2007 | By: | /s/ MICHAEL BARTH |
Michael Barth |
||
Chief
Financial Officer
|